In the past half month, a number of listed companies in the pharmaceutical industry have announced the reduction of shareholders' shareholding, involving Teyi Pharmaceutical, BrightPharmaceutical, WuXi AppTec, etc
.
It is worth noting that these pharmaceutical companies have suffered multiple reductions this year
.
For example, recently, Teyi Pharmaceutical announced that Chen Xiliang, a director and senior manager holding 0.
1753% of the shares, plans to reduce his holding of no more than 175,000 shares of the company by concentrated bidding within 6 months after 15 trading days from the date of disclosure of the announcement, that is, no more than 0.
0767%
of the company's total share capital.
It is reported that on November 9, before that, Teyi Pharmaceutical issued the "Announcement on Shareholders Holding More than 5% of the Shares to Reduce Their Holdings by More than 1%", and its shareholder Xu Lifang reduced her holdings by a total of 4.
200 million shares on November 8, 2022, accounting for 1.
8948%
of the company's current total share capital.
On December 5, BrightPharma announced that the second largest shareholder, Borui Xinwen, plans to reduce its holdings of the company's shares through centralized bidding transactions within 3 months after 15 trading days from the date of disclosure of this announcement, and the total number of shares to be reduced will not exceed 1% of the company's total share capital, that is, no more than 4.
2246 million shares
.
As of the disclosure date of this announcement, Borui Xinwen holds 35.
2511 million shares of the company's shares, accounting for 8.
34%
of the company's total share capital.
The shares are derived from shares held by the Company prior to its IPO and were listed and outstanding
on November 8.
Like Teyi Pharmaceutical, on November 15, BrightPharma also issued an announcement that its major shareholder Zhong Weifang plans to reduce its shares in the company through block transactions within 3 months after 3 trading days from the date of disclosure of this announcement, and the total number of shares to reduce will not exceed 2% of the company's total share capital, that is, no more than 8.
2 million shares
.
On November 25, WuXi AppTec issued the "Notice Letter of Reduction Plan"
.
Due to their own capital needs, the shareholders controlled by the actual controller of the company and the shareholders who have signed a concerted action agreement with the actual controller plan to reduce their holdings of the company's A shares through centralized bidding and/or block trading according to market conditions, and the total number of shares to be reduced shall not exceed 65 million shares, that is, the total shall not exceed 2.
2%
of the total share capital of the company as of November 24, 2022.
It is worth mentioning that this reduction is less than 2 months
after the last reduction.
After the last announcement of large reductions, the secondary market responded
with a drop limit.
After the announcement of the reduction, on November 28, WuXi AppTec's share price plunged 7.
16%.
In fact, for many investors behind WuXi AppTec, the reduction of holdings has long been "strange"
.
According to data disclosed by Flush Software, from July 2019 to September 2021, WuXi AppTec's shareholders reduced their holdings 86 times, with a total amount of 32.
61 billion yuan, and in the third quarter of 2021, Li Ge and Zhao Ning, the actual controllers of WuXi AppTec at the time of listing
, have withdrawn from the top ten shareholders of the company.
Industry analysts believe that the frequent reduction of holdings by listed companies does not mean that the industry has passed, because there are many reasons for shareholders to reduce their holdings, including supplementary liquidity, personal financial conditions, business needs, investment in new fields, and providing borrowing support for listed companies, etc.
, some of which are used for the development of
pharmaceutical companies themselves.
In general, frequent reductions are also a reminder to investors that they need to carefully analyze the reasons for their reductions and the actual use of
the funds.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
